Shopping Cart
- Remove All
Your shopping cart is currently empty
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | Inquiry | Backorder | |
| 5 mg | Inquiry | Backorder |
| Description | CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A). It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway. |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.